Dillon Associates Inc Lowers stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Dillon Associates Inc reduced its stake in Stryker Corporation by 1.58% during the most recent quarter end. The investment management company now holds a total of 102,611 shares of Stryker Corporation which is valued at $11,858,753 after selling 1,645 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Stryker Corporation makes up approximately 5.21% of Dillon Associates Inc’s portfolio.

Other Hedge Funds, Including , Pictet Asset Management Ltd boosted its stake in SYK in the latest quarter, The investment management firm added 177,770 additional shares and now holds a total of 612,614 shares of Stryker Corporation which is valued at $70,799,800. Stryker Corporation makes up approx 0.27% of Pictet Asset Management Ltd’s portfolio. Sivik Global Healthcare added SYK to its portfolio by purchasing 50,000 company shares during the most recent quarter which is valued at $5,745,000. Stryker Corporation makes up approx 2.69% of Sivik Global Healthcare’s portfolio.Pbwm Holdings reduced its stake in SYK by selling 85 shares or 3.46% in the most recent quarter. The Hedge Fund company now holds 2,375 shares of SYK which is valued at $272,888. Stryker Corporation makes up approx 0.10% of Pbwm Holdings’s portfolio. Everett Harris Co Ca added SYK to its portfolio by purchasing 1,680 company shares during the most recent quarter which is valued at $192,898. Stryker Corporation makes up approx 0.01% of Everett Harris Co Ca’s portfolio.

Stryker Corporation opened for trading at $114.44 and hit $116.39 on the upside on Monday, eventually ending the session at $116.28, with a gain of 1.61% or 1.84 points. The heightened volatility saw the trading volume jump to 16,68,588 shares. Company has a market cap of $43,524 M.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *